Congress sends Obama bill on Zika drug development

U.S. lawmakers on Tuesday approved a bill to provide financial incentives to companies developing treatments for the Zika virus, and the White House said President Barack Obama was expected to sign the legislation although it is insufficient to meet the challenge. The measure allows the Food and Drug Administration to include Zika drug developers in the agency's priority review voucher program. The House of Representatives passed the bill on a voice vote, without a roll call, weeks after the same measure was approved by the Senate.